Recent Finacing
Recent Raise
Appia Bio is a Los Angeles-based biotech developing allogeneic, hematopoietic stem cell–derived CAR-iNKT therapies using its ACUA platform for CAR and TCR gene engineering to produce off-the-shelf cancer treatments.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Appia Bio.
